Medicare Rx Plans To Cover Fewer Medications Next Year
Main Category: Medicare / Medicaid / SCHIPArticle Date: 05 Dec 2007 - 5:00 PDT
| Patient / Public: | ![]() |
4.67 (3 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
| Article Opinions: | 1 posts |
The number of medications covered under Medicare prescription drug plans offered by the 10 health insurers with the largest enrollment will decrease next year by 26%, according to a recent analysis by Avalere Health, USA Today reports. According to the analysis, the number of medications covered under Medicare prescription drug plans offered by UnitedHealth and Humana next year will decrease by 30%, from more than 3,750 treatments to more than 2,620, although the plans will continue to have some of the largest formularies available.
The decrease in the number of medications covered under Medicare prescription drug plans will occur "mainly because of changes made by Medicare," which no longer will reimburse plans for treatments that FDA has removed from the market, are considered less than effective, have duplicative billing codes or are no longer manufactured, USA Today reports. CMS officials and health insurers maintain that the decrease likely will not affect Medicare beneficiaries who take medications no longer covered by prescription drug plans because they will have access to alternative treatments and can use an appeals process to seek continued coverage of their current treatments. Humana spokesperson Tom Noland said, "As the Part D program develops, the size of the formulary is becoming more aligned with utilization patterns, consumer preferences, health outcomes and value for consumers" (Appleby, USA Today, 12/4).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our medicare / medicaid / schip section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/90724.php>
APA
http://www.medicalnewstoday.com/releases/90724.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Formularies Shrink For Unstated Reasons
posted by Former Pharmacist on 7 Dec 2007 at 8:49 pmI too noted a very lean formularies. In the past, I had a choice of plans. This year, the closest plan with a below-benchmark premium will not cover 3 of my 11 drugs, which is quite the change. Those three were for non-life-threatening conditions (allergies and eczema). However, for the Medicare Prescription Drug Plan Finder to not include any of the antihistamine-anticholingeric combination products (e.g., Extendryl) is evidence the drug plans are not following Chapter 6, page 9, of the Medicare Part D Manual, which states medications used for conditions in addition to their usage for the common cold (like allergies and asthma) must be covered:
"Cough and cold medications are eligible to meet the definition of a Part D drug in clinically relevant situations other than those of symptomatic relief of cough and colds."
http://www.cms.hhs.gov/PrescriptionDrugCovContra/Downloads/PDBMChap6FormularyReqrmts_03.09.07.pdf
Therefore, I conclude that the plans are cutting corners wherever they can by not following the spirit of Medicare regulations. It is not good medical practice to limit people who have get better allergy relief from such products just because someone might be prescribed it for the common cold. Such usage can be easily distinguished by the type of doctor ordering it (allergist versus internist) as well has for the length of time the prescription is for. Most doctors are not going to write for a 30-day supply or more of anything for the common cold. Usage beyond 10-14 days could easily be used by the plans to distinguish the usage for an approved indication like allergies.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




